Subscribe

Kingfa Science & Technology (India) Limited (KINGFA.NS)

INR5,074.50 +18.50 (+0.37%)
IN NSE Basic Materials Chemicals - Specialty
Address Dhun Building 600002
Chennai, IN
CEO Dazhong Wang
Website kingfaindia.com
IPO 2010-01-08
ISIN INE473D01015

Explore sections of this company profile

Also trades on Bombay Stock Exchange · KINGFA.BO (INR) National Stock Exchange of India · KINGFA.NS (INR)
Description

Kingfa Science & Technology (India) Limited, headquartered in Chennai, India, is a prominent manufacturer and supplier of advanced polymer solutions within the country. The company specializes in producing reinforced polypropylene compounds and fiber-reinforced composites. Their comprehensive product lineup further includes HYPRENE-branded thermoplastic elastomers, POM, fiberglass honeycomb composite panels, LFT (Long Fiber Thermoplastic) and PA6/PA66 materials, a diverse array of engineering plastics compounds, and high-temperature resistant nylon/LCP (Liquid Crystal Polymer) solutions. These versatile materials find extensive application across numerous industries, serving sectors such as automotive manufacturing, electronic appliances, industrial equipment, consumer goods, packaging, and even toys. Established in 1983, the company previously operated under the name Hydro S&S Industries Limited until its rebranding as Kingfa Science & Technology (India) Limited in March 2016. It functions as a subsidiary of Kingfa Sci. & Tech. Co., Ltd.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR5,074.50 +18.50 (+0.37%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
8.7K
Beta
0.62
Float Shares
2.08M
Free Float %
15.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-3.24% -4.85% +11.94% +20.25% +23.02% +19.27% +57.36% +163.75% +484.64% +501.43% +501.43%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
5,074.50
DCF (Unlevered) 5,673.22 +11.8%
DCF (Levered) 1,137.46 -77.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
15.36
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Chemicals - Specialty: +4.7%
    +17.4% ★ Q1'26: +23.2% (vs Q1'25)
  • ✓
    EPS growth Chemicals - Specialty: +13.2%
    +24.8% ★ Q1'26: +26.2% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +3.0% ★ Q1'26: +7.2% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +12.2% ★ Q1'26: +13.5% (vs Q1'25)
  • ✓
    ROIC Chemicals - Specialty: +5.6%
    +21.1% ★ Q1'26: +23.3% (vs Q1'25)
  • ✗
    Share dilution Chemicals - Specialty: +0.1%
    +0.0% Q1'26: +11.9% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    0.18× ★ Q1'26: 0.04× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.64) × ERP
WACC = 100% × Ke + 0% × Kd (24.4%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 7,162.88 Current price: 5,074.50
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2010
actual 		Mar 2011
actual 		Mar 2018
actual 		Mar 2019
actual 		Mar 2020
actual 		Mar 2021
actual 		Mar 2022
actual 		Mar 2023
actual 		Mar 2025
actual 		Mar 2026
1 Rev. Ana.
1 EPS Ana. 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana. 		Mar 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
1.09B
est: 1.10B (-1.0%)
1.40B
est: 1.45B (-3.8%)
6.02B
est: 6.01B (+0.2%)
7.02B
est: 7.35B (-4.6%)
7.42B
est: 7.71B (-3.9%)
6.27B
est: 8.64B (-27.4%)
10.48B
est: 10.38B (+0.9%)
14.04B
est: 12.48B (+12.4%)
17.45B
est: 6.01B (+190.5%)
6.01B
6.01B – 6.01B
+0.0% YoY
7.35B
7.35B – 7.35B
+22.4% YoY
7.71B
7.71B – 7.71B
+4.9% YoY
8.64B
8.64B – 8.64B
+12.0% YoY
EBITDA
67.73M
est: 99.59M (-32.0%)
87.81M
est: 128.53M (-31.7%)
468.51M
est: 542.19M (-13.6%)
393.04M
est: 663.67M (-40.8%)
458.48M
est: 696.26M (-34.2%)
259.52M
est: 779.81M (-66.7%)
595.97M
est: 521.74M (+14.2%)
1.30B
est: 1.13B (+15.0%)
2.34B
est: 1.49B (+57.7%)
1.49B
1.49B – 1.49B
+0.0% YoY
1.82B
1.82B – 1.82B
+22.4% YoY
1.91B
1.91B – 1.91B
+4.9% YoY
2.14B
2.14B – 2.14B
+12.0% YoY
EBIT
43.70M
est: 85.37M (-48.8%)
60.93M
est: 110.17M (-44.7%)
403.20M
est: 464.75M (-13.2%)
306.62M
est: 568.87M (-46.1%)
356.13M
est: 596.81M (-40.3%)
102.06M
est: 668.43M (-84.7%)
466.32M
est: 624.96M (-25.4%)
1.16B
est: 970.72M (+19.6%)
2.13B
est: 1.44B (+48.2%)
1.44B
1.44B – 1.44B
+0.0% YoY
1.76B
1.76B – 1.76B
+22.4% YoY
1.84B
1.84B – 1.84B
+4.9% YoY
2.06B
2.06B – 2.06B
+12.0% YoY
Net Income
-152.0K
10.48M
est: 9.16M (+14.4%)
246.40M
est: 233.14M (+5.7%)
190.55M
est: 293.70M (-35.1%)
246.17M
est: 345.05M (-28.7%)
53.22M
est: 413.35M (-87.1%)
306.33M
est: 331.42M (-7.6%)
814.10M
est: 744.80M (+9.3%)
1.53B
est: 233.14M (+555.6%)
233.14M
233.14M – 233.14M
+0.0% YoY
293.70M
293.70M – 293.70M
+26.0% YoY
345.05M
345.05M – 345.05M
+17.5% YoY
413.35M
413.35M – 413.35M
+19.8% YoY
SGA
—
est: 51.22M (-100.0%)
—
est: 66.10M (-100.0%)
288.47M
est: 278.85M (+3.4%)
282.04M
est: 341.33M (-17.4%)
297.09M
est: 358.10M (-17.0%)
254.43M
est: 401.07M (-36.6%)
413.57M
est: 472.55M (-12.5%)
498.42M
est: 568.96M (-12.4%)
1.35B
est: 278.85M (+383.3%)
278.85M
278.85M – 278.85M
+0.0% YoY
341.33M
341.33M – 341.33M
+22.4% YoY
358.10M
358.10M – 358.10M
+4.9% YoY
401.07M
401.07M – 401.07M
+12.0% YoY
EPS
-0.02
1.53
est: 0.75 (+103.2%)
20.51
est: 19.25 (+6.5%)
15.73
est: 24.25 (-35.1%)
20.33
est: 28.49 (-28.6%)
4.39
est: 34.13 (-87.1%)
25.29
est: 45.70 (-44.7%)
67.22
est: 61.19 (+9.9%)
126.21
est: 19.25 (+555.6%)
19.25
19.25 – 19.25
+0.0% YoY
24.25
24.25 – 24.25
+26.0% YoY
28.49
28.49 – 28.49
+17.5% YoY
34.13
34.13 – 34.13
+19.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-06-01 B+ 3/5 3/5 4/5 5/5 3/5 2/5 2/5
2026-05-29 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-27 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-26 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-25 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-22 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-21 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-20 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 C- 1/5 4/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
878.88M
OE per share TTM
68.05
Owner's Yield
1.22%
Maintenance CapEx ratio
139.70%
Maint CapEx / Avg PPE
20.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P Emerging Markets Small Cap ETF EWX 0.02% 139.6K 0.65%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
8.40M
Shares Outstanding
13.55M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Doraiswami Balaji Executive Director 11M male
Bo Jingen Chairman & MD 2M male
Dazhong Wang Chief Executive Officer — male
Deepak Vyas Company Secretary & Compliance Officer — male
Pranam Ray Head of Sales & Marketing - PPE Division — —
R. Jeevanandam Business Unit Head of South — —
Rahul Dev Business Unit Head of North — —
S. Shanmugasundaram Business Unit Head of West — —
Sun Yajie Chief Technology Officer & Executive Director — male
Chen Xiaoqiong Chief Financial Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty